LabCorp 2012 Annual Report Download - page 6

A Trusted Partner to
Health Care Stakeholders,
Providing Knowledge to
Optimize Decision Making,
Improve Health Outcomes
and Reduce Treatment Costs
ACQUISITIONS
LITHOLINK/CDS
INTERPRETATION
EDUCATIONAL
TOOLS
OTHER INPUTS
SCIENCE
IT CAPABILITIES
BEACONLBS
CLEAR MISSION A Trusted Knowledge Partner
LABORATORY CORPORATION OF AMERICA
4
• The rapid evolution of next-generation sequencing tech-
nology provides new opportunities to offer cost-effective,
innovative molecular diagnostic testing. We recently
launched the GenSeq®: Cardio test, which uses next-
generation sequencing technology to identify more than
90 genetic causes of familial cardiac disease. We believe
that GeneSeq Cardio will be a useful prognostic tool to
identify positive family history and symptoms of several
cardiac conditions as well as early-onset coronary artery
disease. These assays will help establish and confi rm the
diagnosis of familial cardiac disease and identify the need
for regular cardiac screening, lifestyle changes or interven-
tion to prevent progression of cardiac complications.
Our fi fth strategic pillar is to develop alternative delivery
models.
Dramatic and fundamental changes are taking place in our
industry. We see health care moving toward large health
systems, integrated delivery networks, ACOs, patient-
centered medical homes and mega-physician practices.
We also see managed care companies organizing ACOs
and acquiring physician practices. Our capabilities provide
an end-to-end lab solution for these customers, meeting
the requirements of new care models with population
health management tools, decision support programs,
patient counseling, integrated clinical reports and patient-
centric data solutions. These offerings are focused around IT,
but it is the completeness of our solution for lab needs that
differentiates LabCorp – and builds trusted knowledge
partnerships with our customers.
Our BeaconLBSSM platform is a point-of-care decision support
service that interfaces with test ordering systems to assist
physicians in lab and test selection. Physicians, patients and
payers will benefi t from this innovation, which will improve
quality and more effectively manage costs without disrupting
physician workfl ow. Our rules engine interfaces with payer
policies for ordering, utilization, adjudication and payment.
In time we will integrate BeaconLBSSM with our decision
support tools delivered at the point of results, providing
physicians with comprehensive tools to support their delivery
of effective, effi cient care.
Strong Capabilities, Sound Strategy, Clear Vision
Transformational change is under way in U.S. health care. We
enthusiastically embrace the opportunity to broaden our con-
tributions and add value to partnerships with stakeholders.
LabCorp has the right strategy, the right capabilities and the
right vision to prosper in this dynamic environment. Our con-
tinued success will be built by the efforts of our 34,000
employees, each of whom is dedicated to the customers we
are proud to serve. I am grateful to our employees and our
shareholders for their continued support.
Very truly yours,
Dave King
Chairman and Chief Executive Offi cer